Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors

被引：0

作者：

Jie Yin

Kerim Babaoglu

Chad A Brautigam

Lindsay Clark

Zhenhua Shao

Thomas H Scheuermann

Charles M Harrell

Anthony L Gotter

Anthony J Roecker

Christopher J Winrow

John J Renger

Paul J Coleman

Daniel M Rosenbaum

机构：

[1] University of Texas Southwestern Medical Center,Department of Biophysics

[2] Merck Research Laboratories,Department of Structural Chemistry

[3] Merck Research Laboratories,Department of Neuroscience

[4] Merck Research Laboratories,Department of Medicinal Chemistry

来源：

Nature Structural & Molecular Biology | 2016年 / 23卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Human orexin receptors (hOX1R and hOX2R) are GPCRs involved in sleep regulation. Structures of hOX1R bound to a selective antagonist or to a dual antagonist, functional assays and computational analyses reveal the basis for subtype selectivity.

引用

页码：293 / 299

页数：6

共 50 条

[1] Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Yin, Jie
Babaoglu, Kerim
Brautigam, Chad A.
Clark, Lindsay
Shao, Zhenhua
Scheuermann, Thomas H.
Harrell, Charles M.
Gotter, Anthony L.
Roecker, Anthony J.
Winrow, Christopher J.
Renger, John J.
Coleman, Paul J.
Rosenbaum, Daniel M.
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2016, 23 (04) : 293 - 299
[2] Distinct recognition of OX1 and OX2 receptors by orexin peptides
Ammoun, S
Holmqvist, T
Shariatmadari, R
Oonk, HB
Detheux, M
Parmentier, M
Åkerman, KEO
Kukkonen, JP
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02): : 507 - 514
[3] Structure-Activity Relationships of 1-Benzoylazulenes at the OX1 and OX2 Orexin Receptors
Turku, Ainoleena
Leino, Teppo O.
Karhu, Lasse
Yli-Kauhaluoma, Jari
Kukkonen, Jyrki P.
Wallen, Erik A. A.
Xhaard, Henri
CHEMMEDCHEM, 2019, 14 (09) : 965 - 981
[4] OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Thompson, Miles D.
Xhaard, Henri
Sakurai, Takeshi
Rainero, Innocenzo
Kukkonen, Jyrki P.
FRONTIERS IN NEUROSCIENCE, 2014, 8
[5] A comparison of the distribution of orexin A and the orexin receptors, OX1 and OX2, in lean and obese Zucker rats
Bewick, GA
Smith, SL
Viggers, JA
Guerin, CJ
Heal, DJ
Cheetham, SC
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U81 - U81
[6] Biochemical and Electrophysiological Characterization of Almorexant, a Dual Orexin 1 Receptor (OX1)/Orexin 2 Receptor (OX2) Antagonist: Comparison with Selective OX1 and OX2 Antagonists
Malherbe, Pari
Borroni, Edilio
Pinard, Emmanuel
Wettstein, Joseph G.
Knoflach, Frederic
MOLECULAR PHARMACOLOGY, 2009, 76 (03) : 618 - 631
[7] No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children
Melen, Krister
Jalkanen, Pinja
Kukkonen, Jyrki P.
Partinen, Markku
Nohynek, Hanna
Vuorela, Arja
Vaarala, Outi
Freitag, Tobias L.
Meri, Seppo
Julkunen, Ilkka
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2020, 3
[8] Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
Turku, Ainoleena
Borrel, Alexandre
Leino, Teppo O.
Karhu, Lasse
Kukkonen, Jyrki P.
Xhaard, Henri
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8263 - 8275
[9] Expression of orexin receptors 1 (OX1) and 2 (OX2) in hypothalamus and adenohypophysis in cycling female and male rats
Libertun, Carlos
Silveyra, Patricia
Catalano, Paolo N.
Lux-Lantos, Victoria
FRONTIERS IN NEUROENDOCRINOLOGY, 2006, 27 (01) : 97 - 98
[10] ALMOREXANT Dual Orexin OX1/OX2 Antagonist Treatment of Sleep Disorders
Owen, R. T.
Castaner, R.
Bolos, J.
Estivill, C.
DRUGS OF THE FUTURE, 2009, 34 (01) : 5 - 10

← 1 2 3 4 5 →